RANDOMIZED PHASE-III TRIAL OF CHEMO-IMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-III, OPTIMAL DISEASE OVARIAN-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

被引:12
作者
ALBERTS, DS
MASONLIDDIL, N
OTOOLE, RV
ABBOTT, TM
KRONMAL, R
HILGERS, RD
SURWIT, EA
EYRE, HJ
BAKER, LH
机构
[1] ARIZONA CANC CTR,TUCSON,AZ 85724
[2] OHIO STATE UNIV,CTR HLTH,COLUMBUS,OH 43210
[3] SW ONCOL GRP,CTR BIOSTAT,SEATTLE,WA 98104
[4] UNIV NEW MEXICO,ALBUQUERQUE,NM 87131
[5] WAYNE STATE UNIV,MED CTR,DETROIT,MI 48201
关键词
D O I
10.1016/0090-8258(89)90842-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:16 / 21
页数:6
相关论文
共 21 条
[21]   ADVANCED OVARIAN ADENOCARCINOMA - PROSPECTIVE CLINICAL-TRIAL OF MELPHALAN (L-PAM) VERSUS COMBINATION CHEMOTHERAPY [J].
YOUNG, RC ;
CHABNER, BA ;
HUBBARD, SP ;
FISHER, RI ;
BENDER, RA ;
ANDERSON, T ;
SIMON, RM ;
CANELLOS, GP ;
DEVITA, VT .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (23) :1261-1266